Month: May 2019

Innovate UK Grant to Fund Development of Novel Antibiotics for Drug Resistant TB Awarded to Demuris

Demuris has secured a £342,160 grant from Innovate UK to continue the development of a novel class of antibiotics for the treatment of multi-drug resistant Mycobacterium tuberculosis (MDR-TB). Demuris, in collaboration with Newcastle University, has discovered a series of novel natural product antibiotics related to a rifamycin analogue called Kanglemycin1. Semi-synthetic rifamycin antibiotics (rifampicin, rifabutin) …

Innovate UK Grant to Fund Development of Novel Antibiotics for Drug Resistant TB Awarded to Demuris Read More »